SGLT2 Inhibitors
SGLT2 Inhibitors Medications and Options
SGLT2 inhibitors are non-insulin medicines used in care plans for some adults with type 2 diabetes. This product category helps patients and caregivers compare single-ingredient options, related combination tablets, and supporting diabetes resources before opening a product page. Use it to narrow by medication class, brand or generic name, and the questions you need to confirm with your prescriber.
The class name refers to sodium-glucose cotransporter 2 (a kidney protein involved in glucose reabsorption). These medicines may lower blood sugar by helping the body pass more glucose in urine. Some are also discussed in cardiovascular, heart failure, or kidney-related care, but individual use depends on a clinician’s assessment.
Browse SGLT2 inhibitors by medication type
This collection includes product pages for medications such as Jardiance, Farxiga, and Invokana. These pages help you compare product names, active ingredients, forms shown on the listing, and prescription-related details without treating the category as dosing guidance.
Some listings combine an SGLT2 medicine with another diabetes drug. Synjardy combines empagliflozin and metformin, while Invokamet combines canagliflozin and metformin. These combination listings can help when your prescription names both ingredients, but suitability depends on the prescription and medical history.
When a listing includes both brand and active ingredient language, favor the wording on your prescription. A pharmacist or prescriber can clarify whether a generic-name page, brand-name page, or combination product matches the intended therapy.
How to compare product pages
Start with the active ingredient, because brand names and generic names can appear together. Empagliflozin, dapagliflozin, and canagliflozin are examples in this class. If your prescription names a brand, check the listed ingredient as well as the product title.
- Ingredient: Match the active ingredient named on your prescription.
- Medication type: Note whether it is single-ingredient or combined with metformin.
- Form and strength: Use only the strength your prescriber specified.
- Class match: Separate SGLT2 medicines from metformin, insulin, DPP-4 inhibitors (another non-insulin class), and GLP-1 receptor agonists (incretin-based medicines).
- Questions to save: Ask your clinician about heart, kidney, weight, or tolerability concerns.
Quick tip: Keep your prescription label nearby when comparing similar brand and ingredient names.
Common class comparisons before you narrow the list
Many shoppers compare this class with metformin, DPP-4 inhibitors, GLP-1 medicines, and insulin products. These categories work differently and are not interchangeable. A prescriber may choose one medicine or a combination based on A1C (average blood sugar over about three months), kidney function, cardiovascular history, tolerability, and other medicines.
Metformin is often the first comparison because many patients recognize the name. It is not an SGLT2 medicine, and it does not answer the same browsing question. Use that page when you need to verify the separate metformin product, then return to this collection for class-specific options.
| Comparison point | How it helps browsing |
|---|---|
| SGLT2 product pages | Use this category for class-specific names, single-ingredient items, and metformin combinations. |
| Metformin | Metformin remains a common reference point, but no medicine replaces it for everyone. |
| DPP-4 inhibitors | This separate class has its own product list and comparison questions. |
| GLP-1 medicines | Ozempic and Trulicity belong to a different non-insulin class, not this one. |
Why it matters: Similar medication names can hide meaningful differences in class, ingredients, and prescribing requirements.
Safety and access details to check
Every product page should be viewed alongside your prescription directions and medication history. Potential side effects of SGLT2 inhibitors can include genital yeast infections, urinary symptoms, and dehydration; rare but serious risks can occur. People with certain kidney issues, a history of ketoacidosis (dangerous blood acid buildup), or planned surgery may need special review.
Do not use this category to change an SGLT2 inhibitor dose or to decide whether a contraindication applies to you. A prescriber can weigh kidney function, current diabetes therapy, other medicines, and the reason the medicine was chosen. CanadianInsulin.com operates as a prescription referral platform and may support prescription detail checks with the prescriber when required.
When permitted, licensed third-party pharmacies manage dispensing. Some patients also review cash-pay options when eligible, but access rules can vary by jurisdiction and prescription status.
Related diabetes medication categories
The broader Diabetes Medications category may help when your prescription history spans insulin and non-insulin products. Use class-specific categories when you already know the drug family, and broader categories when you are still sorting names.
SGLT2 medicines are one part of a broader non-insulin medication group. The Non-Insulin Diabetes Medications category can help compare nearby classes, while Combination Tablets focuses on products that pair more than one active ingredient. If your prescriber mentioned DPP-4 therapy, DPP-4 Inhibitors groups that separate class for easier scanning.
These related product lists are useful when your prescription or medication history includes more than one class. They also help separate a product category from an educational article, so you can move between listings and background reading without mixing their purposes.
Articles for extra context
Product listings show what is available to compare, while educational pages explain terms you may see on labels or prescriptions. The Type 2 Diabetes Articles archive is useful when you want plain-language background on medication classes, blood sugar terms, and treatment conversations.
For focused reading, SGLT2 Medication Names and Safety Notes can help distinguish a list of SGLT2 inhibitor drugs from a product page. It also gives context for questions about uses, mechanism of action, weight changes, cardiovascular benefits, heart failure, side effects, and contraindications. Use articles to prepare better questions, not to replace clinical advice.
Before you choose your next product page
Use this collection to move from class-level questions to specific product details. Check whether a listing matches the medicine named on your prescription, whether it is single-ingredient or combination, and which questions still need a clinician or pharmacist. SGLT2 inhibitors can be discussed as part of broader diabetes, heart, or kidney care, but the right next page depends on the prescription information you already have.
This content is for informational purposes only and is not a substitute for professional medical advice.
Filter
Product price
Product categories
Conditions
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Frequently Asked Questions
How should I compare SGLT2 inhibitor products?
Compare the active ingredient first, then the brand name, product type, listed form, and prescription details. Single-ingredient products and combination tablets can serve different roles. Do not compare them by dose alone. A clinician or pharmacist should confirm whether a listing matches the medication, strength, and directions on your prescription.
Are Ozempic and Trulicity SGLT2 inhibitors?
No. Ozempic and Trulicity are GLP-1 receptor agonists, a different non-insulin medicine class. SGLT2 medicines include products such as empagliflozin, dapagliflozin, and canagliflozin. The classes work differently and are not interchangeable. If your prescriber mentioned both, confirm which product and active ingredient belong on your prescription.
Can SGLT2 inhibitor products be combined with metformin?
Some product listings are combination tablets that include an SGLT2 medicine and metformin. These products are different from taking a single-ingredient SGLT2 medicine or metformin alone. Whether a combination fits depends on the prescription, kidney function, tolerability, and treatment history. A prescriber should decide which ingredients and strength are appropriate.
What safety details should I check before using this category?
Use the category to identify product names and related medication classes, not to self-select therapy. Safety details to discuss include side effects, contraindications, kidney function, dehydration risk, surgery plans, and other medicines you take. The product page and prescription label can help organize questions, but a clinician should interpret risks for your situation.
Related Articles
Research, Weight Management
How to Get Retatrutide: Legal Access and Safety Checks
Retatrutide access depends first on regulatory approval. If you are searching for how to get retatrutide, start by checking whether a regulator has approved a specific product where you live.…
Diabetes, Type 1
Continuous Glucose Monitoring: How CGMs Fit Diabetes Care
Continuous glucose monitoring is a way to track glucose throughout the day and night with a small wearable sensor. It matters because it shows patterns, direction, and alerts that a…
Diabetes, Endocrine &
What Is Glucagon Like Peptide 1 and What Does It Do?
What is glucagon like peptide 1? In simple terms, it is a hormone your gut releases after you eat. Clinically, it is called glucagon-like peptide-1, or GLP-1, an incretin (a…
Type 2 Diabetes,
Does Metformin Cause Weight Loss? Expectations and Limits
Yes, metformin can cause modest weight loss in some people, but it is not primarily a weight-loss drug. If you are asking does metformin cause weight loss, the practical answer…